Bausch Health shares gain momentum as the company reports $2.94 billion in Q3 revenue and lifts its financial outlook following an 8% organic growth performance.
Bausch Health demonstrated strong financial momentum in Q3 2026, achieving $2.94 billion in consolidated revenues, which represents a 10% increase on a reported basis and 8% on an organic basis compared to the previous year. This performance, coupled with a GAAP net income of $436 million, underscores the company's successful operational execution and growth trajectory. The positive revenue growth across both reported and organic metrics suggests sustained demand for its core product portfolio.
Bausch Health reported consolidated revenues of $2.94 billion, marking a 10% increase on a reported basis and an 8% increase on an organic basis.
The GAAP net income attributable to Bausch Health was $436 million.
Bausch Health Companies reported a strong third quarter with consolidated revenues reaching $2.94 billion, marking a 10% increase over the previous year. The company posted GAAP net income of $436 million, supported by an 8% organic growth rate that prompted management to raise its full-year financial guidance.
Bausch Health reported $2.94 billion in revenue, representing a 10% increase, alongside $436 million in GAAP net income.